semax

Nootropic peptide (PRO8,GLY9,PRO10) Semax Acetate CAS 80714-61-0

Semax is a drug which is used mostly in Russia and Ukraine for a broad range of conditions but predominantly for its purported nootropic, neuroprotective, and neurorestorative properties. Semax has not been evaluated, approved for use, or marketed in most other countries.

Category:

Semax acetate

ACTH (4-7), Pro-Gly-Pro-

CAS 80714-61-0

MF C37H51N9O10S

MW  813.92

Application Research purpose

Semax is an experimental drug that was originally developed back in Russia to prevent and treat circulatory disorders. It has also been identified as a “nootropic” or “cognitive enhancer.” Also known as the Heptapeptide SEMAX (MEHFPGP), it is the analog of ACTH.

Related products